Heavy! National cancer, cardiovascular disease and other medical and therapeutic status published.

Recently, the National Health And Health Committee held a press conference, the Chinese Academy of Sciences, the National Center for Cancer Professional Quality Control Center, the National Cancer Center Director He Jie, the
Chinese Academy of Engineering, the National Digestive Endoscopy Professional Quality Control Center Director Li Zhaoshen, deputy director of the National Cardiovascular Center Zheng Zhe on China's cancer diagnosis, digestive endoscopy quality and cardiovascular disease issued relevant information.
the five-year survival rate of malignant tumors increased by 10% in the past 10 years
in 2014, China's new cases of cancer about 3.804 million, accounting for about 22% of the global incidence of cancer, the incidence rate is slightly lower than the world average, death s2.296 million, accounting for 27% of global deaths, higher than the world average.
the standardization of tumor diagnosis and treatment and quality control work has been strengthened.
since the establishment of the National Cancer Quality Control Center, efforts to improve the level of standardized diagnosis and treatment of tumors, committed to the construction of national, provincial and municipal three-level tumor quality management and control system, and actively promote the establishment of provincial and municipal cancer quality control centers, has now established 28 provincial quality control centers, municipal quality control centers are also set up. Centers have made positive contributions to improving the quality of medical care and ensuring medical safety, while the National Cancer Big Data Platform is being built, connecting 14 provincial cancer hospitals and collecting more than 1.5 million cancer hospital patients, which will make the quality control of tumors more accurate.
the development of new technologies in cancer treatment, the ability of primary medical institutions to continue to improve.
in recent years, the application of medical innovation technology has significantly improved the level of tumor diagnosis and treatment, with thoracic laparoscopy, robot as the representative of minimally invasive surgical technology, widely used in lung cancer and other common malignant tumors treatment, significantly reduce the trauma of patients, improve the efficacy. The application of three-dimensional shape, adjustment, image guidance, stereoscopic orientation and other technologies has greatly improved the accuracy of radiation therapy positioning and irradiation, so that the survival rate of nasopharyngeal cancer, prostate cancer, breast cancer and so on has increased by about 5-10%.
the application of new technologies such as high-throughput gene sequencing, liquid biopsy, drug concentration monitoring and the use of molecularly targeted drugs, promoting clinical precision drug use and effectively improving the quality of survival and survival of patients with advanced stage. The application of multidisciplinary treatment models, including surgery, chemotherapy, radiotherapy, targeting and immunotherapy, has also significantly improved the effectiveness of diagnosis and treatment.
the primary hospital gradually undertake the diagnosis and treatment of common tumors, the ability to improve diagnosis and treatment is particularly important, for this reason, we actively promote various forms of tumor medicine and specialized alliance construction, in the primary medical institutions to promote the application of key technologies for prevention and control, help grass-roots organizations to build and develop specialized, through direct staff to carry out specialist outpatient and multidisciplinary diagnosis and treatment mechanisms, to serve patients at the same time, fundamentally enhance the capacity of grass-roots tumor diagnosis and treatment.
the prevention and treatment of cancer has achieved good results.
National Cancer Center has established 574 cancer registration monitoring points, covering 430 million people, accounting for about 31.5% of the country's population, and regularly publishes the annual report of China's cancer registration. With the improvement of medical quality and diagnosis and treatment ability in China, the five-year survival rate of malignant tumors has increased from 30.9% 10 years ago to 40.5%, of which the increase is significant: uterine cancer, from 55.1% to 72.8%, thyroid cancer, from 67.5% to 84.3%, cervical cancer, from 45.4% to 59.8%, and bone tumor, from 17.1%. 26.5%; esophageal cancer, from 20.9% to 30.3%, the five-year survival rate of some tumors has been higher than the United States and other developed countries, such as esophageal cancer, the United States in the same period only 20%, according to the number of cases, leukemia, central nervous system tumors, lymphoma accounted for 66.2% of all childhood tumors, China's overall five-year survival rate of childhood malignant tumors is about 72%, slightly lower than the United States 78%. Among them, 70.5 percent of leukemia and 69.9 percent of central nervous tumors, close to the United States levels of 74 percent and 72 percent.
Although China's five-year survival rate of tumors has been greatly improved, but the overall compared with developed countries still have room for improvement. Next, the National Cancer Center and the National Cancer Center will continue to strengthen tumor quality control and standardized diagnosis and treatment work, promote the formation of the tumor classification diagnosis and treatment system, promote the application of new technologies in tumor treatment and accelerate the process of new drug research and development, and continuously improve the level of cancer diagnosis and treatment at all levels of medical institutions.
the number of digestive endoscopy cases in China is the world's first
digestive endoscopy technology has become an indispensable clinical gastrointestinal diseases and biliary pancreatic disease a very important means, has been the majority of patients or clinical staff welcome.
Although the development of digestive endoscopy in China started late, but the state attaches great importance to the work of this sector, from the beginning of the introduction and development of digestive endoscopy technology to get the government's concern at all levels, especially in the past 40 years of reform and opening up, the state's strong investment in medical digestive endoscopy, digestive endoscopy also occurred into the fast lane, we often talk about digestive endoscopy technology has been running behind other countries, a few years ago we have come to and run stage, can now be proud to say that China's digestive endoscopy from treatment or research and development has reached a leading level.
since 2012 to now do a Chinese digestive endoscopy statistics, from the data can see the speed and quality of China's digestive endoscopy, in 2015 when the country has more than 6000 medical institutions to carry out endoscopy, nearly 30,000 digestive endoscopy doctors can do endoscopy, while nearly 20,000 nurses responsible for the endoscopy of some care work, a year can complete nearly 30 million cases of digestive endoscopy, the world's social impact of a large number of patients.
our digestive endoscopy from a professional point of view or complex operation, etc. there are certain risks, in the early stages of our country digestive endoscopy is scarce, there is no training system, and the prevalence rate is not too high, there is a certain rate of missed diagnosis or even some complications. Many patients tell me that there is a particular fear of endoscopy, and that there is some fear of endoscopy safety, fear of cross-infection. To this end, in previous years under the leadership of the Ministry of Health, the quality of digestive endoscopy has been greatly revitalized, the implementation of a series of effective measures to strengthen prosecution, hard to implement, and achieved some results.The first of the
is to strengthen the top-level design
, issued a series of regulations on the digestive endoscopy technology management, to improve the quality of China's digestive endoscopy treatment provides a strong policy guarantee. It should be said that the management norms of digestive endoscopy are further refined, and a monitoring of the whole process of digestive endoscopy quality is realized in China.the second
is the establishment of the national digestive endoscopy quality control system
, for the development of digestive endoscopy quality control work to provide a solid organizational guarantee. China's digestive endoscopy quality work is beginning to rely on the association or society, in 2015 when the organization set up the digestive endoscopic quality control expert group, in 2017 set up the national digestive endoscopic control center, while the provinces and autonomous regions to set up different levels of quality control center, so far, the vast majority of our cities have a related quality control system. At the same time, a big data network platform for digestive endoscopy control was set up, and the implementation of diagnosis and treatment classification was initially realized. the third
is to carry out systematic research
, in order to improve the quality of China's digestive endoscopy provides a practical basis for supervision. Beginning in 2016, the National Digestive Control Center annually organized the national census of the quality control of the digestive endoscopy, and conducted real-time sampling research, formed a research report 5 times in the new mechanism, formulated industry guidelines and norms have 12, and put forward suitable for China's national conditions of the digestive endoscopy quality control standards, in the country to promote the application. The quality survey carried out by the provincial and municipal quality control centers adds up to more than 200 times, through research and found that standards and guidelines have been fully implemented, so far China's digestive endoscopy quality control inspection has basically achieved normal, institutionalized, covering the country's medical institutions at all levels.
after these years of efforts, China's digestive endoscopy quality has been greatly improved, can be said to have reached the international advanced level. For example, the digestive endoscope operation difficulty of pancreatic bile duct imaging and ultrasound endoscope. At present, China's success rate reached 95%, should be said to be the same as the United States and other developed countries, and the incidence of digestive endoscopy complications is significantly lower than other countries. The World shocked the world in 2016 when ANERCP tested for a superbug infection that killed five people. As the director of the National Digestive Endoscopy Center, I am very worried, in five provinces and cities in the country nearly 100 hospitals for flight inspection, not a case of non-conformity.
we used to rely on imports of medical equipment, in recent years, China's digestive endoscopy equipment independent research and development efforts gradually increased, especially on the basis of remote control capsules, with complete independent intellectual property rights, to reach the international leading level, has been General Secretary Xi and national leaders attach great importance to and affirm, can carry out gastrointestinal pain-free examination.
digestive endoscope has made a lot of achievements, but we should also work harder, we should be in these areas to strengthen, first of all, endoscopy technology to go deep into the grass-roots level, to further pay attention to the grass-roots level, the center of gravity down, the pass forward. And we need to continue to strengthen normative training, especially tumor screening, we must combine the screening of large data and artificial intelligence to improve the ability to make early diagnosis.
the number of cardiovascular diseases in China reached 290 million
the incidence and rise rate of cardiovascular diseases in China are on the rise, the number of cardiovascular diseases in China is estimated to reach 290 million, cardiovascular surgery is the main treatment of coronary heart disease, heart disease, since the reform and opening up, our country's entire cardiovascular surgery team is growing, can carry out cardiovascular surgery reached 484, by 2016 reached 723, the number of medical treatment has increased by nearly doubled.
the field of cardiovascular surgery is the largest is a pre-cardiac disease, accounting for more than 30%, in recent years we have complex pre-cardiac disease diagnosis and treatment capacity in a significant improvement. One of the operations, called double-root transfer surgery, was invented by our country, internationally recognized, and included in the continuing education curriculum of American doctors.
bypass surgery is also a very important way to treat coronary heart disease. From some data, the success rate of bypass surgery is significantly improved, the number of days in hospital is shortening, which is a very important change. A recent study published in the International Journal of Medical Medicine shows that our nation's hospitals have the same rate of hospitalization and complications as in the United States. Now a lot of people talk about doing an operation is not to go abroad to do, in fact, it is not necessary, in the country can also get good treatment. Like heart transplants, for example, as our national organ donation efforts are getting better and better, the number of heart transplants is increasing, with 442 heart transplants completed in 2017, especially our survival rates such as early surgery, one-year survival, five-year survival and 10-year survival rates, all 10 to 15 percentage points higher than the international average.
in addition, just mentioned by Guo Bureau artificial heart, is the cardiovascular field of the highest technical content of one aspect, previously completely carried out by Europe and the United States, we basically can not use, recently we fully developed a new type of artificial heart for clinical use, yesterday in the Focus Interview has a patient is a year ago rescue treatment, he can now drive himself, life is very good. This reflects our progress.
there are other techniques, such as the combination of surgical and interventional techniques, we are called hybridization technology, originally thought to be very critical patients, through the relatively small trauma approach to good treatment.
overall, the development of cardiovascular surgery, from the last century is also called running, because more often than not, many doctors study abroad, come back to carry out some technology. By now we have gone from and running to the lead in some technologies, some of which we can say outnumber foreign countries. A very obvious example, we used to study abroad more, but now we actually accept a large number of doctors from abroad to study in China, including some countries in Europe and the Americas. Previously we thought those countries were of a high level, but now they are on our side.
but another aspect, we should also note that accessibility is increasing, but in homogeneity, although some large hospitals are very high level, but some small and medium-sized hospitals compared to the level of a certain gap, which requires us to strengthen the national quality control work. In 2017, the National Cardiovascular Disease Quality Control Center will further strengthen the medical quality management and control of cardiovascular specialties in China, and this work will further jointly establish the national provincial hospital three-level quality control center, and build a national information quality control platform. At the same time, we also set up a scientific and clear quality control indicators, cardiovascular professional national quality and control work, and strive to improve the whole profession, especially cardiovascular surgery homogeneity.
future cardiovascular surgery continues to accelerate innovation and transformation of new technologies with quality and innovation to provide the best care for our nation's cardiovascular surgery patients.
.